Article Details

EU HTA Regulation: 'Stepping Beyond' JCAs May Be Needed For Very Rare Disease Drugs

Retrieved on: 2025-05-06 21:55:05

Tags for this article:

Click the tags to see associated articles and topics

EU HTA Regulation: 'Stepping Beyond' JCAs May Be Needed For Very Rare Disease Drugs. View article details on hiswai:

Excerpt

... therapy conference said ... This was the conclusion of speakers at the Alliance For Regenerative Medicine's Cell & Gene Meeting.

Article found on: insights.citeline.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo